Results 121 to 130 of about 18,813 (211)

Hydrophobic Tag Degraders Overcome Endocrine-Resistant Breast Cancer by Recruiting HSP27-Mediated E3 Ligase Complex for ERα Proteasomal Degradation. [PDF]

Angew Chem Int Ed Engl
Xin L, Song Z, Cui Y, Wang C, Chen Y, Liu J, Min J, Hu Z, Xiao R, Liu X, Guo Z, Wang H, Hu Z, Huang J, Liang K, Dong C, Zhou HB.   +16 more
europepmc   +1 more source

Proteostasis Dysfunction and Heat Shock Protein Networks in Intervertebral Disc Degeneration: Molecular Mechanisms and Therapeutic Opportunities. [PDF]

Curr Issues Mol Biol
Wang Z, Chen S, Wang Z, Sun Y, Wang K, Kang X.   +5 more
europepmc   +1 more source

Phenoxazine Derivative ST61 Displays an Oxidative-Stress-Mediated Cytotoxic Activity Against Human Cancer Cells. [PDF]

Biomolecules
Papadopoulou A, Avgeris S, Thysiadis S, Siokatas C, Astaras S, Soukou F, Mavrogonatou E, Pratsinis H, Voutsinas GE, Sarli V, Kletsas D.   +10 more
europepmc   +1 more source

Microtubule Cytoskeleton Dysfunction in Chronic Pain: Mechanisms of Transport Failure and Emerging Therapeutic Targets. [PDF]

Int J Mol Sci
Li Z, Liu J, Chu T, Gao F.
europepmc   +1 more source

Extracellular Hsp27 in patients with chronic kidney disease [PDF]

Kidney International, 2013
Kinga, Musiał, Danuta, Zwolińska
openaire   +2 more sources

HSP27 functional switch drives castration-resistant prostate cancer via mTOR pathway activation, highlighting promising combination therapies. [PDF]

J Exp Clin Cancer Res
Duong QH, Le TK, Tran TT, Audebert S, Camoin L, Nguyen NG, Baboudjian M, Giusiano S, Phan UTT, Zaghdoudi S, Adelaide J, Baylot V, Gleave M, Garrido C, Taïeb D, Rocchi P.   +15 more
europepmc   +1 more source

Proteomic profiling of pulpal and periapical diseases: a systematic review. [PDF]

Front Dent Med
Rai AS, Iype AM, Bhat R, Shetty P.
europepmc   +1 more source

Heat Shock Proteins in Cancer: Mechanisms and Therapeutic Targeting. [PDF]

MedComm (2020)
Ma S, Liu CQ, Ma SY, Wang SG, Xia QD, Xu MY.   +5 more
europepmc   +1 more source

Heat Shock Proteins as Targets for Cancer Therapeutics. [PDF]

J Clin Med
Trikala A, Shen B, Bhardwaj S.
europepmc   +1 more source

Blood-Brain Barrier (BBB)-Penetrable Androgen Receptor (AR) Degrader as a Potential Therapeutic Agent for Glioblastoma. [PDF]

ACS Pharmacol Transl Sci
Zhao X, Li Y, Martin WR, Salem F, Korem R, Bolbol S, Worden G, Sajid M, Al-Rousan A, Wilt B, Zhang W, Turchyn L, Hubert C, Ning L, Lathia JD, Zhou A, Su B.   +16 more
europepmc   +1 more source